Annette Sperl
Overview
Explore the profile of Annette Sperl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hillerich V, Valbert F, Neusser S, Pfaar O, Klimek L, Sperl A, et al.
Eur J Health Econ
. 2023 Jul;
25(4):579-600.
PMID: 37414970
Background: Allergic rhinitis (AR) and allergic asthma (AA) are chronic respiratory diseases that represent a global health problem. One aim of this study was to analyze the Health-related Quality of...
2.
Bousquet J, Anto J, Sousa-Pinto B, Czarlewski W, Bedbrook A, Haahtela T, et al.
Clin Transl Allergy
. 2023 Jan;
13(1):e12215.
PMID: 36705508
MASK-air , a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to...
3.
Valbert F, Neusser S, Pfaar O, Klimek L, Sperl A, Werfel T, et al.
Clin Exp Allergy
. 2022 May;
52(12):1422-1431.
PMID: 35524545
Background: Allergen immunotherapy (AIT) represents the only possibility of causal therapy for allergic respiratory diseases. Although the prevailing high prevalence of allergic diseases and restrictions in the daily lives of...
4.
Kantar A, Klimek L, Cazan D, Sperl A, Sent U, Mesquita M
Multidiscip Respir Med
. 2020 Apr;
15(1):511.
PMID: 32269775
Ambroxol (2-amino-3,5-dibromo-N-[trans-4-hydroxycyclohexyl]benzylamine), an over-the-counter product, is a mucoactive agent and has been used widely to treat both acute and chronic respiratory diseases since 1978. This review aims to provide an...
5.
Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, et al.
Allergol Select
. 2020 Mar;
3(1):22-50.
PMID: 32176226
Background: The number of patients affected by allergies is increasing worldwide. The resulting allergic diseases are leading to significant costs for health care and social systems. Integrated care pathways are...
6.
Klimek L, Chaker A, Casper I, Sperl A, Strieth S, Mosges R
Laryngorhinootologie
. 2020 Jan;
99(1):56-66.
PMID: 31935757
Adequate diagnostical workup for respiratory allergies and consequent therapy in children determine the individual course of disease. Therapy consists first of symptomatic treatment and includes in the next step the...
7.
Klimek L, Sperl A, Becker S, Mosges R, Tomazic P
Expert Opin Pharmacother
. 2018 Nov;
20(1):83-89.
PMID: 30439290
Introduction: Allergic rhinitis is a common condition with increasing prevalence and is associated with several comorbid disorders such as bronchial asthma and atopic dermatitis. If allergen avoidance is not possible,...
8.
Cazan D, Klimek L, Sperl A, Plomer M, Kolsch S
Expert Opin Drug Saf
. 2018 Oct;
17(12):1211-1224.
PMID: 30372367
Ambroxol is a widely used secretolytic and mucoactive over-the-counter agent primarily used to treat respiratory diseases associated with viscid mucus. Following post-marketing reports of hypersensitivity reactions and severe cutaneous adverse...
9.
Klimek L, Sperl A, Worm M, Ring J
MMW Fortschr Med
. 2017 Nov;
159(Suppl 3):76-84.
PMID: 29086254
No abstract available.
10.
Klimek L, Poletti S, Sperl A, Spielhaupter M, Bardenhewer C, Mullol J, et al.
Int Forum Allergy Rhinol
. 2016 Nov;
7(3):287-292.
PMID: 27888645
Background: The purpose of this study was to investigate the effect of MP-AzeFlu on olfaction and the interaction between severity of allergic rhinitis and olfactory improvement after therapy. Methods: A...